News

  • All Posts
  • Case studies
  • News
New NIH grant awarded

New NIH grant awarded

FilamenTech is pleased to announce participation in a new NIH-funded scientific project: "Analysis Tools for Fiber Diffraction of Muscle" (R01GM144555),...

Read More
FILAMENTECH LOGO-02-white

Human cardiac prediction from data you already have.

FilamenTech develops multiscale mechanistic simulation workflows that help drug-development teams translate assay, tissue, animal, mutation, and structural data into human-relevant cardiac and muscle predictions.

Boston • Belgrade

Linkedin

Explore

Company

Start with a focused pilot.

Evaluate mutation effects, drug responses, or translational hypotheses using mechanistic simulation workflows tailored to your program.

Discuss a project
See if your dataset fits

© 2026 FilamenTech. All rights reserved.

Created by Starter studio.